4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006312
President sold 30,000 shares at an average $57.39 ($1,721,580)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 1 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-27 | Sale : show line 2 in the form | −6,387 | $58.19 | $371,660 | 8,613 | D |
| 2021-01-27 | Sale : show line 3 in the form | −6,913 | $59.37 | $410,425 | 1,700 | D |
| 2021-01-27 | Sale : show line 4 in the form | −1,700 | $59.99 | $101,983 | 0 | D |
| 2021-01-28 | Exercise or conversion : show line 5 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-28 | Sale : show line 6 in the form | −3,433 | $54.96 | $188,678 | 10,567 | D |
| 2021-01-28 | Sale : show line 7 in the form | −9,420 | $55.96 | $527,143 | 2,147 | D |
| 2021-01-28 | Sale : show line 8 in the form | −2,147 | $56.68 | $121,692 | 0 | D |
| Open-market sales · 30,000 sh · avg $57.39 · $1,721,580 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −15,000 | 125,000 | D |
| 2021-01-28 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −15,000 | 110,000 | D |
Loading xslF345X03/doc4.xml…